Non-Invasive Respiratory Monitoring Market size was over USD 9.09 billion in 2024 and is projected to reach USD 19.87 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of non-invasive respiratory monitoring is assessed at USD 9.54 billion. The reason behind the growth is impelled by the growing burden of respiratory disorders across the globe. The two greatest causes of death in the world are lung cancer and chronic obstructive pulmonary disease driven by growing tobacco smoking, and rising air pollution, dust, and chemicals from the workplace.
For instance, more than 330 million individuals worldwide are thought to be affected by asthma, and the illness is thought to be the cause of around 240,000 annual fatalities.
The growing advancements in noninvasive monitoring of blood gases are believed to fuel the market growth. Improvements in the noninvasive monitoring of arterial and venous blood gases, could all contribute to a significant improvement in respiratory monitoring.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.2% |
|
Base Year Market Size (2024) |
USD 9.09 billion |
|
Forecast Year Market Size (2037) |
USD 19.87 billion |
|
Regional Scope |
|
Product (Spirometer, Pulse Oximeter, Peak Flow Meter, Capnographs)
The spirometer segment is predicted to account for 40% share of the global non-invasive respiratory monitoring market in the coming years owing to the benefits provided by spirometry. Spirometry is particularly helpful as a noninvasive respiratory monitoring method of measuring airflow restriction since it is reasonably simple to implement. The most often used technique for tracking breathing is spirometry whereby the patient is required to breathe into a spirometer during the test to gauge how much air they can inhale and expel, which takes a few minutes to complete.
A lung assessment device known as a spirometer counts the amount of air breathed in and out of the lungs every minute and aids in maintaining the health of the lungs by facilitating deep, leisurely breathing. Once trained, spirometry is a simple procedure that may be carried out anywhere and can be carried out by anyone to ascertain the effects of drugs, measure lung damage, track the impacts of occupational and environmental exposures, and detect the existence or absence of lung illness.
In addition, the simple, painless method of determining the blood's oxygen saturation level is pulse oximetry which displays pulse rates and blood oxygen saturation levels with accuracy in less time. They have an LED display, which makes it easier to understand the results, and are often used by sports enthusiasts, cyclists, mountain climbers, and anyone else who wants to swiftly monitor their SpO2 as they are convenient.
Similarly, a peak flow meter is a little, affordable, handheld gadget tool that can help to assess how effectively asthma is controlled, and how well one can expel air from the lungs. The quantity of air that a person can swiftly blast out of their lungs in one breath is known as their peak expiratory flow rate, or PEFR, which is quantified by peak flow meters.
End-User (Hospitals, Clinics, Home care)
The hospitals segment is set to garner a notable share shortly. The demand for non-invasive respiratory monitoring in hospitals is driven by advancements in medical technology and the need for more efficient and comfortable healthcare delivery. Non-invasive techniques, such as pulse oximetry, capnography, and respiratory impedance, allow healthcare providers to monitor respiratory function to detect early signs of respiratory distress and prevent complications.
Furthermore, technological advancements in non-invasive respiratory monitoring devices have led to the expansion of their use across hospitals.
Moreover, non-invasive respiratory monitoring plays a crucial role in enhancing patient safety and comfort during procedures by reducing the risk of adverse events such as hypoxemia, hypoventilation, and respiratory arrest.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
End-User |
|
North American Market Forecast
Non-Invasive Respiratory Monitoring Market in North America is predicted to account for the largest share of 40% by 2037 impelled by the increasing spending in healthcare. As a result, there is an increasing demand for non-invasive respiratory monitoring technologies in the region which offers several advantages such as reduced patient discomfort. For instance, spending on health care in the United States increased by more than 4% in 2022 to reach around USD 4 trillion.
European Market Statistics
The Europe Non-Invasive Respiratory Monitoring Market is estimated to be the second largest, during the forecast timeframe led by growing health awareness. The necessity of maintaining excellent health and well-being has become more widely recognized as a result of the efforts put in place in Europe, which may drive the demand for non-invasive respiratory monitoring.
APAC Market Analysis
Also, the market in the Asia Pacific, is poised to hold a significant share by the end of 2037 driven by growing urbanization. This has a significant impact on the nation's air pollution owing to a lack of amenities such as proper roads, efficient transit management, and an unplanned industrial distribution, which has led to several respiratory issues.
For instance, in India, more than 460 million people live in urban areas, and this figure is increasing annually by over 2%.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?